The IFN-inducible protein 16 (IFI16) has been detected in sera from patients with autoimmune/inflammatory diseases but not in healthy subjects. This leaking leads to loss of tolerance towards this self-protein and the development of autoantibodies. In this study, clinical significance of both IFI16 protein and anti-IFI16 antibodies (Abs) in rheumatoid arthritis (RA) was investigated.
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis
Caneparo, Valeria;GARIGLIO, Marisa;
2016-01-01
Abstract
The IFN-inducible protein 16 (IFI16) has been detected in sera from patients with autoimmune/inflammatory diseases but not in healthy subjects. This leaking leads to loss of tolerance towards this self-protein and the development of autoantibodies. In this study, clinical significance of both IFI16 protein and anti-IFI16 antibodies (Abs) in rheumatoid arthritis (RA) was investigated.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
acr.22695.pdf
file disponibile solo agli amministratori
Tipologia:
Documento in Post-print
Licenza:
DRM non definito
Dimensione
193.72 kB
Formato
Adobe PDF
|
193.72 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
